University of Surrey: New MenB Vaccine Shows Promise in Early-Stage Trial Results
May 16, 2025
May 16, 2025
GUILFORD, England, May 16 -- The University of Surrey issued the following news release:
* * *
New MenB Vaccine Shows Promise in Early-Stage Trial Results
The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group B meningococcus (MenB), a significant cause of meningococcal disease worldwide, and establishes proof-of-concept in humans that a gene-based vaccine platform can induce protectiv . . .
* * *
New MenB Vaccine Shows Promise in Early-Stage Trial Results
The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting group B meningococcus (MenB), a significant cause of meningococcal disease worldwide, and establishes proof-of-concept in humans that a gene-based vaccine platform can induce protectiv . . .